Samsung Biologics Co Ltd
KRX:207940
Samsung Biologics Co Ltd
KRX:207940
Price:
999 999.9999
KRW
Market Closed
Market Cap:
₩82.3T
Relative Value
The Relative Value of one
Samsung Biologics Co Ltd
stock under the Base Case scenario is
hidden
KRW.
Compared to the current market price of 999 999.9999 KRW,
Samsung Biologics Co Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Samsung Biologics Co Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Samsung Biologics Co Ltd Competitors
Samsung Biologics Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 18.1 | 46.1 | 30.1 | 39.4 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
949.8B USD | 332.5 | 3 937.7 | 1 128.4 | 2 172.8 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
179B USD | 4 | 26.7 | 18.8 | 25.3 | |
| US |
|
Danaher Corp
NYSE:DHR
|
131.7B USD | 5.4 | 36.4 | 18.6 | 27 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
33.1B CHF | 5.1 | 35 | 26.1 | 26.1 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
262.9B CNY | 5.9 | 17.4 | 17.4 | 17.4 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
31.6B USD | 4.5 | 24.5 | 19.3 | 23 | |
| US |
|
Waters Corp
NYSE:WAT
|
27.8B USD | 8.8 | 43.2 | 27.9 | 35.1 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
27.6B USD | 1.7 | 20.4 | 11.5 | 17.3 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
23.8B USD | 5.9 | 27.4 | 20.4 | 22.7 | |
| FR |
|
Sartorius Stedim Biotech SA
PAR:DIM
|
15.6B EUR | 5.3 | 58.9 | 20.1 | 31.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
